Patent References 3242051 3436355 3447945 3565559 InventorsAssigneeApplicationNo. 05/611835 filed on 09/09/1975US Classes:424/499, Contains proteins or derivative or polysaccharides or derivative264/4.3, With treatment subsequent to solid wall formation (e.g., coating, hardening, etc.)264/4.6, Solid-walled microcapsule formed by physically removing a constituent (e.g., evaporation, extraction, etc.)424/489, Particulate form (e.g., powders, granules, beads, microcapsules, and pellets)424/500, Contains natural gums and resins427/213.3, Solid encapsulation process utilizing an emulsion or dispersion to form a solid-walled microcapsule (includes liposome)428/402.2, Microcapsule with fluid core (includes liposome)428/402.24, Microcapsule with solid core (includes liposome)514/125, Ketone or aldehyde containing977/775, Nanosized powder or flake (e.g., nanosized catalyst, etc.)977/783, Organic host/matrix (e.g., lipid, etc.)977/915Therapeutic or pharmaceutical compositionExaminersPrimary: Lovering, Richard D.Attorney, Agent or FirmInternational ClassesA61K 9/51 (20060101)B01J 13/06 (20060101) B01J 13/08 (20060101) Foreign Application Priority Data1974-09-18 AUAbstractParticles in the size range from about 10 to about 1000 nm, preferably less than about 500 nm, which comprise a crosslinked matrix of macromolecules of natural origin.A biologically or pharmacodynamically active material may be supported on or incorporated into the matrix. | |